{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:59:59Z","timestamp":1711933199825},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,31]]},"DOI":"10.7759\/cureus.57327","type":"journal-article","created":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T15:05:10Z","timestamp":1711897510000},"source":"Crossref","is-referenced-by-count":0,"title":["Botulinum Toxin Type A in the Treatment of Raynaud\u2019s Syndrome: A Case Report"],"prefix":"10.7759","author":[{"given":"Plamen","family":"Penchev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"Dobrev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petar-Preslav","family":"Petrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remzi","family":"Talib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladislav","family":"Velchev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristiyan","family":"Georgiev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Pathophysiological regulation of the cutaneous vascular system in Raynaud\u2019s phenomenon","author":"Flavahan NA","year":"2014","unstructured":"Flavahan NA. Pathophysiological regulation of the cutaneous vascular system in Raynaud\u2019s phenomenon. Raynaud\u2019s Phenomenon: A Guide to Pathogenesis and Treatment. Wigley FM, Herrick AL, Flavahan NA (ed): Springer New York, New York, NY; 2014. 57-79."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2010.09.019","article-title":"Botulinum toxin type A in the treatment of Raynaud's phenomenon","volume":"35","author":"Neumeister MW","year":"2010","unstructured":"Neumeister MW. Botulinum toxin type A in the treatment of Raynaud's phenomenon. J Hand Surg Am. 2010, 35:2085-92. 10.1016\/j.jhsa.2010.09.019","journal-title":"J Hand Surg Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/1753193413516242","article-title":"A prospective study of the use of botulinum toxin injections in the treatment of Raynaud's syndrome associated with scleroderma","volume":"39","author":"Uppal L","year":"2014","unstructured":"Uppal L, Dhaliwal K, Butler PE. A prospective study of the use of botulinum toxin injections in the treatment of Raynaud's syndrome associated with scleroderma. J Hand Surg Eur Vol. 2014, 39:876-80. 10.1177\/1753193413516242","journal-title":"J Hand Surg Eur Vol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-219348","article-title":"The novel use of botulinum toxin A for the treatment of Raynaud's phenomenon in the toes","volume":"2018","author":"Dhaliwal K","year":"2018","unstructured":"Dhaliwal K, Griffin M, Denton CP, Butler PE. The novel use of botulinum toxin A for the treatment of Raynaud's phenomenon in the toes. BMJ Case Rep. 2018, 2018:10.1136\/bcr-2017-219348","journal-title":"BMJ Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0363-5023(80)80104-3","article-title":"Digital artery sympathectomy","volume":"5","author":"Flatt AE","year":"1980","unstructured":"Flatt AE. Digital artery sympathectomy. J Hand Surg Am. 1980, 5:550-6. 10.1016\/s0363-5023(80)80104-3","journal-title":"J Hand Surg Am"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2011.07.006","article-title":"Botulinum toxin A treatment of Raynaud's phenomenon: a review","volume":"41","author":"Iorio ML","year":"2012","unstructured":"Iorio ML, Masden DL, Higgins JP. Botulinum toxin A treatment of Raynaud's phenomenon: a review. Semin Arthritis Rheum. 2012, 41:599-603. 10.1016\/j.semarthrit.2011.07.006","journal-title":"Semin Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/01.prs.0000244860.00674.57","article-title":"Management of vasospastic disorders with botulinum toxin A","volume":"119","author":"Van Beek AL","year":"2007","unstructured":"Van Beek AL, Lim PK, Gear AJ, Pritzker MR. Management of vasospastic disorders with botulinum toxin A. Plast Reconstr Surg. 2007, 119:217-26. 10.1097\/01.prs.0000244860.00674.57","journal-title":"Plast Reconstr Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2004.01324.x","article-title":"Botulinum toxin in the treatment of Raynaud's phenomenon: a pilot study","volume":"34","author":"Sycha T","year":"2004","unstructured":"Sycha T, Graninger M, Auff E, Schnider P. Botulinum toxin in the treatment of Raynaud's phenomenon: a pilot study. Eur J Clin Invest. 2004, 34:312-3. 10.1111\/j.1365-2362.2004.01324.x","journal-title":"Eur J Clin Invest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2008.11.026","article-title":"Botulinum toxin type A: a treatment option for digital ischemia in patients with Raynaud's phenomenon","volume":"34","author":"Fregene A","year":"2009","unstructured":"Fregene A, Ditmars D, Siddiqui A. Botulinum toxin type A: a treatment option for digital ischemia in patients with Raynaud's phenomenon. J Hand Surg Am. 2009, 34:446-52. 10.1016\/j.jhsa.2008.11.026","journal-title":"J Hand Surg Am"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.40123","article-title":"The therapeutic efficacy of botulinum toxin in treating scleroderma-associated Raynaud's phenomenon: a randomized, double-blind, placebo-controlled clinical trial","volume":"69","author":"Bello RJ","year":"2017","unstructured":"Bello RJ, Cooney CM, Melamed E, et al.. The therapeutic efficacy of botulinum toxin in treating scleroderma-associated Raynaud's phenomenon: a randomized, double-blind, placebo-controlled clinical trial. Arthritis Rheumatol. 2017, 69:1661-9. 10.1002\/art.40123","journal-title":"Arthritis Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.anplas.2011.11.001","article-title":"Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis. (Article in French)","volume":"58","author":"Serri J","year":"2013","unstructured":"Serri J, Legr\u00e9 R, Veit V, Guardia C, Gay AM. Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis. (Article in French). Ann Chir Plast Esthet. 2013, 58:658-62. 10.1016\/j.anplas.2011.11.001","journal-title":"Ann Chir Plast Esthet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13030","article-title":"Beneficial effect of botulinum toxin A on Raynaud's phenomenon in Japanese patients with systemic sclerosis: a prospective, case series study","volume":"43","author":"Motegi S","year":"2016","unstructured":"Motegi S, Yamada K, Toki S, Uchiyama A, Kubota Y, Nakamura T, Ishikawa O. Beneficial effect of botulinum toxin A on Raynaud's phenomenon in Japanese patients with systemic sclerosis: a prospective, case series study. J Dermatol. 2016, 43:56-62. 10.1111\/1346-8138.13030","journal-title":"J Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2018.18013","article-title":"Botulinum toxin type A in the treatment of Raynaud's phenomenon: a three-year follow-up study","volume":"5","author":"Medina S","year":"2018","unstructured":"Medina S, G\u00f3mez-Zubiaur A, Valdeolivas-Casillas N, et al.. Botulinum toxin type A in the treatment of Raynaud's phenomenon: a three-year follow-up study. Eur J Rheumatol. 2018, 5:224-9. 10.5152\/eurjrheum.2018.18013","journal-title":"Eur J Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/242626-botulinum-toxin-type-a-in-the-treatment-of-raynauds-syndrome-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T15:05:13Z","timestamp":1711897513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/242626-botulinum-toxin-type-a-in-the-treatment-of-raynauds-syndrome-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,31]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.57327","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,31]]}}}